[Sponsored] Executives from TailorCare, Altera Digital Health, and WiPro shared insights at the ViVE 2025 conference in Nashville. The post The Vibe at ViVE: Health Tech Leaders Share Insights from AI to Value-based Care appeared first on MedCity News.
The clinical trial process is complex, long, and always arduous. But the results of the drug development process can be amazing, new, safe, effective, life-changing, and life-enhancing therapies. The post Challenges and Opportunities for Digital Innovation in Clinical Trials appeared first on MedCity News.
WISHIN CEO Steve Rottmann details HIE’s role in value-based care, quality measurement, and tracking health-related social needs
From Hwang, Jakob and Squires (2025) in AER: Insights: Cousin marriage rates are high in many countries today. While previous studies have documented increased risks of infant and child mortality, we provide the first estimate of the effect of such marriages on life expectancy throughout adulthood. By studying couples married over a century ago, we…
A list of interesting articles to checkout as you head to the weekend. How America Built the World’s Most Successful Market for Generic Drugs.Reference Pricing as a Deterrent to Entry.Will Florida Medicaid cover a hospitalization in South Dakota?Will better data rescue value-based care?The return of COVID?
The Host Mary Agnes Carey KFF Health News @maryagnescarey Read Mary Agnes’ stories. The midterm elections are months away, yet changes at the Department of Health and Human Services suggest the Trump administration is focusing on how to win on health care, which remains a top concern for voters. Facing growing concern about the administration’s…
Healthcare leaders who shape that future need more than innovation. They need a visible, credible voice that helps the people around them — patients, clinicians, employees, partners, and investors — understand what the change is, why it matters, and why this is the right person to lead it. The post The Healthcare Leaders Driving Change…
This analysis examines PEPFAR spending and HIV viral suppression rates in 22 countries from 2018–2023 to help identify which investments most effectively drive HIV outcomes and inform future directions.
The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to review the mRNA shot and then quickly reversed its position. But a recommendation from a Centers for Disease Control and Prevention advisory committee is key for payer coverage, and that committee has not met all year…
Several healthcare leaders are supporting the Biden-Harris administration’s proposed rule to expand Medicare and Medicaid coverage of GLP-1 medications for obesity treatment. The post Health Leaders Applaud Biden’s Proposal to Expand Medicare/Medicaid Coverage for Anti-Obesity Medications appeared first on MedCity News.